Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets close in 4 hours 11 minutes
FTSE 100
8,296.88
+83.39
(+1.02%)
FTSE 250
20,394.53
+229.99
(+1.14%)
AIM
777.16
+5.63
(+0.73%)
GBP/EUR
1.1649
-0.0010
(-0.09%)
GBP/USD
1.2543
-0.0021
(-0.17%)
Bitcoin GBP
51,106.38
-178.19
(-0.35%)
Money
The retirement income gap no-one is talking about
People are living longer than ever before and this can impact how you plan for retirement
NexgenRx Inc. (NXG.V)
TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.2200
0.0000
(0.00%)
At close: 03:11PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
13,846
13,846
12,781
11,841
11,041
Cost of revenue
3,026
3,026
2,598
2,028
1,376
Gross profit
10,820
10,820
10,183
9,813
9,666
Operating expenses
Selling general and administrative
1,274
1,274
1,269
805.851
789.975
Total operating expenses
10,964
10,964
9,895
7,614
7,508
Operating income or loss
-143.876
-143.876
287.658
2,199
2,158
Interest expense
28.932
28.932
22.127
55.534
208.552
Income before tax
-305.055
-305.055
134.467
2,010
1,810
Income tax expense
26.915
26.915
156.868
-2,008
-305.765
Income from continuing operations
-331.97
-331.97
-22.401
4,018
2,116
Net income
-331.97
-331.97
-22.401
4,018
2,116
Net income available to common shareholders
-331.97
-331.97
-22.401
4,018
2,116
Basic EPS
-0.01
-0.01
-0.00
0.06
0.03
Diluted EPS
-0.01
-0.01
-0.00
0.05
0.03
Basic average shares
70,482
70,531
70,336
70,336
69,919
Diluted average shares
75,674
70,531
70,336
74,836
74,186
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.